Cannabinoids modulate pain by multiple mechanisms of action
- 1 January 2000
- journal article
- Published by Elsevier in The Journal of Pain
- Vol. 1 (1) , 2-14
- https://doi.org/10.1016/s1526-5900(00)90082-8
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- A second endogenous cannabinoid that modulates long-term potentiationNature, 1997
- The Perceived Effects of Smoked Cannabis on Patients with Multiple SclerosisEuropean Neurology, 1997
- Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptorsBiochemical Pharmacology, 1995
- Nabilone in the treatment of multiple sclerosisThe Lancet, 1995
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trialArchiv Fur Psychiatrie Und Nervenkrankheiten, 1990
- Evaluation of Intramuscular Levonantradol and Placebo in Acute Postoperative PainThe Journal of Clinical Pharmacology, 1981
- Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smokingClinical Pharmacology & Therapeutics, 1980
- The analgesic properties of delta‐9‐tetrahydrocannabinol and codeineClinical Pharmacology & Therapeutics, 1975
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964